Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Jim Mac who wrote (634)	7/9/1998 8:04:00 PM
From: Tompj	Read Replies (1) \| Respond to of 1754

I still think that this stock will rise big time in the next few days before earnings. The reason: 1.They will beat estimates ( look at past history) 2. Small share float and big shot interest ( I estimate over 30% of the trading shares are shorting VISX. SHORTS WILL HAVE TO COVER. 3. This is a hot industry and people like to see (its better than a search engine)

To: Jim Mac who wrote (634)	7/16/1998 11:31:00 AM
From: admr	Read Replies (1) \| Respond to of 1754

I read your post. Going forward visx will do well with incresaing nearsighted patients using th excimer laser. However, the use of the excimer laser in hyperopia, presbyopia is a difficult procedure, invasive and not without complications. The Sunrise Tech Laser using LTK Holmium laser will be the laser of choice for the above indications. It is much easier to use, less complications. I believe they are submitting to the FDA in October with approval in 1999. The excimer will get approval this year but for hyperopia, presbopia and overcorrection resulting from PRK and Lasik treatments for myopia its clear that the Sunrise Laser will be used. The excimer will be for these indications be obsolete in six months. Andrew Richman M.D,